1. Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice and humans
- Author
-
Progatzky, Fränze, Jha, Akhilesh, Wane, Madina, Thwaites, Ryan S., Makris, Spyridon, Shattock, Robin J., Johansson, Cecilia, Openshaw, Peter J., Bugeon, Laurence, Hansel, Trevor T., Dallman, Margaret J., Imperial College Healthcare Trust Biomedical Research Centre (BRC), Imperial College Healthcare NHS Trust- BRC Funding, Medical Research Council (MRC), National Institute for Health Research, Rosetrees Trust, Jha, Akhilesh [0000-0002-8413-7738], and Apollo - University of Cambridge Repository
- Subjects
Adult ,Gills ,Male ,Allergy ,Immunology ,mucosal innate immunity ,vaccine adjuvants ,Respiratory Mucosa ,nasal respiratory mucosa ,Article ,INFLAMMATION ,comparative cross-species analysis ,resiquimod ,INFECTION ,Animals ,Humans ,NASAL ,Immunity, Mucosal ,Zebrafish ,IN-VIVO ,Science & Technology ,Toll-Like Receptors ,Imidazoles ,Middle Aged ,Immunity, Innate ,Mice, Inbred C57BL ,1107 Immunology ,CELLS ,Cytokines ,ASTHMA ,Female ,Life Sciences & Biomedicine - Abstract
We compared live zebrafish, mouse and human nasal challenge responses to the TLR7/8 agonist resiquimod (R848). We found remarkably similar induction of mediators in the three species, offering novel mucosal models of innate anti-viral immunity.
- Published
- 2019